E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/4/2016 in the Prospect News High Yield Daily.

New Issue: Acadia Healthcare prices $390 million 6½% eight-year notes at par

By Paul A. Harris

Portland, Ore., Feb. 4 – Acadia Healthcare Co. Inc. priced a $390 million issue of eight-year senior notes (B3/B) at par to yield 6½% on Thursday, according to an informed source.

The yield printed at the tight end of the 6½% to 6¾% yield talk. That talk had tightened through the week, as the deal was being marketed, sources said.

Initial guidance had the bonds pricing in the low 7% yield context, which gave way later in the week to talk in the high 6% context.

Shortly before official talk surfaced on Thursday, discussions had ratcheted down to 6 5/8%, according to a trader, who added that the $390 million deal was believed to be playing to between $3 billion and $4 billion of orders.

BofA Merrill Lynch was the left bookrunner. Jefferies LLC was the joint bookrunner.

The Franklin, Tenn.-based provider of inpatient behavioral health care services plans to use the proceeds to help fund the acquisition of Priory, a provider of behavioral health care services in the United Kingdom.

The financing also includes a $955 million term loan.

Issuer:Acadia Healthcare Co., Inc.
Amount:$390 million
Maturity:March 1, 2024
Securities:Senior notes
Left bookrunner:BofA Merrill Lynch
Joint bookrunner:Jefferies LLC
Coupon:6½%
Price:Par
Yield:6½%
Spread:479 bps
First call date:March 1, 2019
Trade date:Feb. 4
Settlement date:Feb. 16
Ratings:Moody's: B3
Standard & Poor's: B
Distribution:Rule 144A with registration rights
Price talk:6½% to 6¾%
Marketing:Roadshow

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.